SEC Form 4 · accession 0001651844-16-000019

NYMOX PHARMACEUTICAL CORP · NYMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 22, 2016

Accepted (ET)

Jun 24, 2016 · 6:13 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001018735

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jun 22, 2016	P	2,500	$3.02	A	2,810,050	D
Common Stock	Jun 22, 2016	P	2,500	$2.85	A	2,812,550	D
Common Stock	Jun 23, 2016	P	2,500	$2.95	A	2,815,050	D
Common Stock	Jun 23, 2016	P	2,500	$2.92	A	2,817,550	D
Common Stock	Jun 23, 2016	P	2,500	$2.88	A	2,820,050	D
Common Stock	Jun 23, 2016	P	2,500	$2.88	A	2,822,550	D
Common Stock	Jun 24, 2016	P	2,500	$3.06	A	2,825,050	D
Common Stock	Jun 24, 2016	P	2,500	$3.03	A	2,827,550	D
Common Stock	Jun 24, 2016	P	2,500	$3.13	A	2,830,050	D
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust

No Table II lines on this filing.